CHI3L1 and glioblastoma: Francescone et al. elucidated the regulatory role of YKL-40 in VEGF production in glioblastoma cell line U87, and demonstrated how blocking YKL-40 activity with monoclonal antibodies is a promising therapeutic strategy for advanced tumors [22].